Effect of Intralipid Infusion in Patients With Recurrent Implantation Failure

NCT02865785 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

320

Enrollment

OTHER

Sponsor class

Conditions

Subfertility

Interventions

DRUG: Intralipid 20%
DRUG: Placebo

Sponsor

Ain Shams University